Literature DB >> 7564113

Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis.

L Biancone1, G Andres, H Ahn, C DeMartino, I Stamenkovic.   

Abstract

Several forms of glomerulonephritis are induced by antibodies against self or foreign antigens. Normal B lymphocyte antibody production requires T cell costimulatory signals provided in part by T cell surface expression of gp39/CD40ligand (CD40L) that engages the B cell receptor CD40 and induces B cell differentiation and immunoglobulin class switching. We assessed the effect of disrupting the CD40L-CD40 costimulatory pathway, using a CD40-Ig fusion protein, on the development of membranous glomerulonephritis (MGN) in the mouse. MGN is induced by mouse antibodies that recognize and bind to exogenously administered rabbit anti-mouse renal tubular brush border (RbAMBB) IgG immobilized in the glomerular capillary wall. MGN did not occur in nude mice, showing the need of the T cell function. C57Bl/10 mice immunized with RbAMBB and treated with CD40-Ig fusion protein displayed a delayed autologous response and absence of MGN lesions, while control fusion proteins failed to prevent the development of the disease. These observations provide evidence that disruption of the CD40-CD40L costimulatory pathway can prevent the development of MGN by suppressing T cell-dependent antibody production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564113     DOI: 10.1038/ki.1995.314

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

Authors:  N S Kenyon; M Chatzipetrou; M Masetti; A Ranuncoli; M Oliveira; J L Wagner; A D Kirk; D M Harlan; L C Burkly; C Ricordi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.

Authors:  G Camussi; E Lupia
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 3.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

Review 5.  Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease.

Authors:  Yuan Min Wang; Jimmy Jianheng Zhou; Ya Wang; Debbie Watson; Geoff Yu Zhang; Min Hu; Huiling Wu; Guoping Zheng; Yiping Wang; Anne M Durkan; David C H Harris; Stephen I Alexander
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

6.  Costimulatory molecule VSIG4 exclusively expressed on macrophages alleviates renal tubulointerstitial injury in VSIG4 KO mice.

Authors:  Yan Li; Yi-Qin Wang; Dai-Hong Wang; Wei-Ping Hou; Ying Zhang; Ming Li; Fu-Rong Li; Jiao Mu; Xiang Du; Fang Pang; Fa-Huan Yuan
Journal:  J Nephrol       Date:  2014-01-15       Impact factor: 3.902

7.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

8.  Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients.

Authors:  Alfons Segarra; Manuel Praga; Natalia Ramos; Natalia Polanco; Isabel Cargol; Elena Gutierrez-Solis; M Rosa Gomez; Bruno Montoro; Joaquim Camps
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-28       Impact factor: 8.237

9.  Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease.

Authors:  L Biancone; G Andres; H Ahn; A Lim; C Dai; R Noelle; H Yagita; C De Martino; I Stamenkovic
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 10.  Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.

Authors:  Keitaro Nishizawa; Tomohisa Yamashita; Yayoi Ogawa; Hironori Kobayashi
Journal:  CEN Case Rep       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.